Guidance: COVID-19: guidance on protecting people defined on medical grounds as extremely vulnerable
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Information for employers about the COVID-19 vaccination programme.
PHE and Porton Biopharma Limited have committed to being more transparent with the public about when, how and why we use animals in research.
A data linkage approach to assessing the contribution of hospital-associated SARS-CoV-2 infection to care home outbreaks in England, 30 January to 12 October 2020.
An epidemiological study comparing the health of those exposed to nuclear weapons tests, to a group of personnel not exposed to radiation.
Form (E53) for genome sequencing for SARS-CoV-2.
Evaluation of the first national ‘Cervical Screening Saves Lives’ campaign which ran in 2019.
Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population.
This document will help providers and commissioners of immunisation services decide the appropriate response to vaccine incidents.
Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population.